comparemela.com

Latest Breaking News On - Parkinson 039s disease - Page 16 : comparemela.com

Michael J Fox Foundation selects platform to help with research

H1, a US data healthcare data technology company has been selected by non-profit funder of Parkinson’s Disease (PD) research, The Michael J Fox Foundation (MJFF), for its Trial Landscape solution.

Maggie kuhlAriel katzMichaelj fox foundationTrial landscapePreclinical researchAtient centricityDelivery technologiesParkinson 039s diseaseNeurodegenerative diseasesClinical trialClinical research

Changes in Gut Bacteria May Cause Parkinson s: Study

Find out why changes in gut health may be an early sign of Parkinson's Disease, long before more common symptoms appear, according to a new study.

Eteläuomen läiRos parkinsonMary kay rossGuy schwartzMovement disorders center at stony brook medicineBrain health research instituteThorne gut health testAmerican college of emergency physiciansUniversity of helsinkiAmerican collegeEmergency physiciansBrain healthResearch instituteStony brook parkinsonMovement disorders centerStony brook medicine

Michael J Fox Foundation selects platform to help with research

H1, a US data healthcare data technology company has been selected by non-profit funder of Parkinson’s Disease (PD) research, The Michael J Fox Foundation (MJFF), for its Trial Landscape solution.

Maggie kuhlAriel katzMichaelj fox foundationTrial landscapePreclinical researchAtient centricityDelivery technologiesParkinson 039s diseaseNeurodegenerative diseasesClinical trialClinical research

Parkinson s Risk 70 Percent Higher for Camp Lejeune Marines; The Cause Could Affect Millions: Study

New study links Parkinson's disease to the water at Camp Lejeune. Marines there between 1975-1985 have a 70% increased risk of developing Parkinson's.

North carolinaUnited statesNew yorkUniversity of rochesterKiribati generalCamp pendletonEarl ray dorseyDepartment of veterans affairsAgency for toxic substancesEuropean unionMarine corpsCamp lejeuneAffected familiesTarawa terraceToxic substancesDisease registry

Breakthrough Tests May Revolutionize Diagnosis of Parkinson s Disease

The absence of any biomarker capable of detecting Parkinson's in the earliest stages has hindered finding new treatments. This may be about to change.

United statesRoger millerChristopher gibbonsKenneth marekLife sciencesInstitute for neurodegenerative disordersEarly diagnosis has hinderedAccurately detectNeurodegenerative disordersLancet neurologyDrug administrationSignificantly impact treatmentEarly detectionNervous systemParkinson 039s diseaseThe epoch times

vimarsana © 2020. All Rights Reserved.